Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: NATIONWIDE PHARMACEUTICAL LLC
Awarding agency: Department of State / Department of State
Funding agency: Department of State / Department of State
Period of performance: 2023-03-04 to 2026-03-03
Current total value of award: $649432
Description: EXERCISE OPTION YEAR 2